Biogen Has Many `Exciting' Drugs in Pipeline: CEO

Jan. 14 (Bloomberg) -- George Scangos, chief executive officer Biogen Idec Inc., talks about the company's multiple sclerosis drugs, pipeline and outlook. Scangos speaks with Erik Schatzker and Stephanie Ruhle on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Parsley CEO Says Company Can Still Profit at $35 Oil
21:24 - Bryan Sheffield, founder and chief executive officer at Parsley Energy, discusses the Trump administration rolling back regulations, the ability to add production, and offers insight on the company's hedging strategy. He speaks with Bloomberg's Alix Steel from the Scotia Howard Weil Energy Conference in New Orleans, Louisiana, on "Bloomberg Markets." (Source: Bloomberg)
  • Germany Said to Make EU Bill a U.K. Brexit Priority
  • Investors Seek Trump Trade Tax Reform Indicators
  • European Stocks Rebound Ahead of Article 50 Trigger